Zobrazeno 1 - 10
of 271
pro vyhledávání: '"Masayuki Hanaoka"'
Autor:
Ryota Ozawa, Kei Sonehara, Tsutomu Hachiya, Shuhei Nozawa, Toshihiko Agatsuma, Hiroshi Yamamoto, Akane Kato, Akemi Matsuo, Taro Hirabayashi, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Abstract Introduction Chemoimmunotherapy is widely used as the first‐line management of advanced non‐small cell lung cancer (NSCLC) in clinical settings. However, predictive factors associated with the development of immune‐related adverse even
Externí odkaz:
https://doaj.org/article/aa42099c35ad42f8a04023c3e61f282a
Autor:
Atsuhito Ushiki, Shunnosuke Tanaka, Miwa Yamanaka, Jumpei Akahane, Yuichi Ikuyama, Masamichi Komatsu, Kei Sonehara, Takashi Ichiyama, Yosuke Wada, Kazunari Tateishi, Yoshiaki Kitaguchi, Masayuki Hanaoka
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Multidrug therapy for Mycobacterium avium complex pulmonary disease (MAC-PD) results in negative sputum cultures. However, the prognostic value of this treatment approach remains unclear. This study aimed to clarify whether multidrug therapy
Externí odkaz:
https://doaj.org/article/8849534b57b44145ac1feeb88c983c29
Autor:
Tatsuya Yazaki, Kei Sonehara, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masanori Yasuo, Masayuki Hanaoka
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 305-310 (2024)
Introduction: Primary tracheal adenoid cystic carcinoma (TACC) is a rare low-grade lung cancer of bronchial gland origin. Surgery is the first choice of treatment; however, in cases of recurrence or inoperability, a combination of radiation and chemo
Externí odkaz:
https://doaj.org/article/9c7586c3b9e24d4c93b14de76598dcfd
Autor:
Yuchen Sun, Kosuke Saito, Atsuhito Ushiki, Mitsuhiro Abe, Yoshinobu Saito, Takeru Kashiwada, Yasushi Horimasu, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Kenji Tsushima, Kazuhisa Takemoto, Rika Ishikawa, Toshiko Momiyama, Shin-ichiro Matsuyama, Noriaki Arakawa, Hirotoshi Akane, Takeshi Toyoda, Kumiko Ogawa, Motonobu Sato, Kazuhiko Takamatsu, Kazuhiko Mori, Takayoshi Nishiya, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-23 (2024)
Abstract Background Drug-induced interstitial lung disease (DILD) is a lung injury caused by various types of drugs and is a serious problem in both clinical practice and drug development. Clinical management of the condition would be improved if the
Externí odkaz:
https://doaj.org/article/1318948710974ad7a181c0d83d189e4d
Autor:
Kei Sonehara, Shuhei Nozawa, Yusuke Suzuki, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 939-945 (2023)
Pulmonary spindle cell carcinoma is a subtype of pulmonary sarcomatoid carcinoma and a very rare tumor type with a poor prognosis. A few case reports have documented patients with pulmonary sarcomatoid carcinoma with anaplastic lymphoma kinase rearra
Externí odkaz:
https://doaj.org/article/10df2b21bccf4e508b48e51ede6a3312
Autor:
Kei Sonehara, Ryota Ozawa, Mineyuki Hama, Shuhei Nozawa, Toshihiko Agatsuma, Kenichi Nishie, Akane Kato, Akemi Matsuo, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Publikováno v:
Thoracic Cancer, Vol 14, Iss 6, Pp 636-642 (2023)
Abstract Background Combination immunotherapy (immune checkpoint inhibitors and cytotoxic anticancer agents) is widely used as first‐line treatment for advanced non‐small cell lung cancer (NSCLC). However, the therapeutic effect of combination im
Externí odkaz:
https://doaj.org/article/9497c8b11ed347c9b0b471268d489d91
Autor:
Kosuke Saito, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Atsuhito Ushiki, Kenji Tsushima, Yoshinobu Saito, Mitsuhiro Abe, Yasushi Horimasu, Takeru Kashiwada, Kazuhiko Mori, Motonobu Sato, Takayoshi Nishiya, Kazuhiko Takamatsu, Yuchen Sun, Noriaki Arakawa, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Drug-induced interstitial lung disease (DILD) occurs when drug exposure causes inflammation of the lung interstitium. DILD can be caused by different types of drugs, and some DILD patterns results in a high mortality rate; hence, DILD poses
Externí odkaz:
https://doaj.org/article/0c7f20c00a684773a7c25ae7391cf65d
Autor:
Noriaki Arakawa, Atsuhito Ushiki, Mitsuhiro Abe, Shinichiro Matsuyama, Yoshinobu Saito, Takeru Kashiwada, Yasushi Horimasu, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Kenji Tsushima, Keiko Miyashita, Kosuke Saito, Ryosuke Nakamura, Takeshi Toyoda, Kumiko Ogawa, Motonobu Sato, Kazuhiko Takamatsu, Kazuhiko Mori, Takayoshi Nishiya, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
No reliable serum biomarker for diffuse alveolar damage, a poor prognosis subtype of drug-induced interstitial lung disease, is currently available. Here, the authors show stratifin/14-3-3σ in serum is a promising biomarker for diagnosis of this typ
Externí odkaz:
https://doaj.org/article/26c767ba6b984eb3ba31e8f03b45e8ce
Autor:
Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu, Kei Sonehara, Satoshi Wasamoto, Shigeru Koyama, Fumiaki Yoshiike, Mineyuki Hama, Kenichi Nishie, Daichi Kondo, Toshihiko Agatsuma, Akane Kato, Munetake Takata, Shintaro Kanda, Masayuki Hanaoka, Tomonobu Koizumi
Publikováno v:
Thoracic Cancer, Vol 13, Iss 14, Pp 2031-2040 (2022)
Abstract Backgrounds The PACIFIC trial established durvalumab consolidation therapy after concurrent chemoradiotherapy (CCRT) as the standard treatment for locally advanced non–small cell lung cancer (LA‐NSCLC). However, little is known about the
Externí odkaz:
https://doaj.org/article/70885b62a3b64f34b89b53fcffcb92c5
Autor:
Masamichi Komatsu, Hiroshi Yamamoto, Takeshi Uehara, Yukihiro Kobayashi, Hironao Hozumi, Tomoyuki Fujisawa, Atsushi Miyamoto, Tomoo Kishaba, Fumihito Kunishima, Masaki Okamoto, Hideya Kitamura, Tae Iwasawa, Shoichiro Matsushita, Yasuhiro Terasaki, Shinobu Kunugi, Atsuhito Ushiki, Masanori Yasuo, Takafumi Suda, Masayuki Hanaoka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Immunoglobulin (Ig) G4-positive cells are rarely observed in the lungs of patients with idiopathic interstitial pneumonias (IIPs). IgG1 may be more pathogenic than IgG4, with IgG4 having both pathogenic and protective roles in IgG4-related d
Externí odkaz:
https://doaj.org/article/fec18f8e8aa64deba90d20daf3177fa1